- Home
- NRO vs AMRN Comparison
NRO vs AMRN Comparison
Compare NRO & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRO
- AMRN
- Stock Information
- Founded
- NRO 2003
- AMRN 1989
- Country
- NRO United States
- AMRN Ireland
- Employees
- NRO N/A
- AMRN N/A
- Industry
- NRO Finance/Investors Services
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- NRO Finance
- AMRN Health Care
- Exchange
- NRO Nasdaq
- AMRN Nasdaq
- Market Cap
- NRO 187.8M
- AMRN 189.2M
- IPO Year
- NRO N/A
- AMRN 1993
- Fundamental
- Price
- NRO $3.55
- AMRN $0.56
- Analyst Decision
- NRO
- AMRN Buy
- Analyst Count
- NRO 0
- AMRN 1
- Target Price
- NRO N/A
- AMRN N/A
- AVG Volume (30 Days)
- NRO 239.4K
- AMRN 1.8M
- Earning Date
- NRO 01-01-0001
- AMRN 02-27-2025
- Dividend Yield
- NRO 11.41%
- AMRN N/A
- EPS Growth
- NRO N/A
- AMRN N/A
- EPS
- NRO N/A
- AMRN N/A
- Revenue
- NRO N/A
- AMRN $241,021,000.00
- Revenue This Year
- NRO N/A
- AMRN N/A
- Revenue Next Year
- NRO N/A
- AMRN N/A
- P/E Ratio
- NRO N/A
- AMRN N/A
- Revenue Growth
- NRO N/A
- AMRN N/A
- 52 Week Low
- NRO $2.51
- AMRN $0.43
- 52 Week High
- NRO $3.45
- AMRN $1.37
- Technical
- Relative Strength Index (RSI)
- NRO 47.34
- AMRN 62.52
- Support Level
- NRO $3.45
- AMRN $0.43
- Resistance Level
- NRO $3.62
- AMRN $0.49
- Average True Range (ATR)
- NRO 0.08
- AMRN 0.04
- MACD
- NRO 0.01
- AMRN 0.01
- Stochastic Oscillator
- NRO 60.00
- AMRN 96.07
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. The fund invests in sectors, such as apartments, Data Centers, Infrastructure REITs, Manufactured Homes, Office, Regional Malls and others.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.